{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T18:31:42Z","timestamp":1790015502930,"version":"4.0.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1016\/j.jaci.2007.09.022","type":"journal-article","created":{"date-parts":[[2007,12,10]],"date-time":"2007-12-10T20:05:58Z","timestamp":1197317158000},"page":"1378-1381","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":146,"title":["Delayed onset and protracted progression of anaphylaxis after omalizumab administration in patients with asthma"],"prefix":"10.1016","volume":"120","author":[{"given":"Susan L.","family":"Limb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter R.","family":"Starke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles E.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Badrul A.","family":"Chowdhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2007.09.022_bib1","unstructured":"Genentech Inc. Xolair (omalizumab): full prescribing information. 2007. Available at: http:\/\/www.gene.com\/gene\/products\/information\/pdf\/xolair-prescribing.pdf. Accessed September 24, 2007."},{"key":"10.1016\/j.jaci.2007.09.022_bib2","unstructured":"Omalizumab: healthcare professional sheet. US Food and Drug Administration. 2007. Available at: http:\/\/www.fda.gov\/cder\/drug\/infopage\/omalizumab\/default.htm. Accessed August 6, 2007."},{"key":"10.1016\/j.jaci.2007.09.022_bib3","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2500\/aap.2007.28.3003","article-title":"Anaphylactoid reactions in two patients after omalizumab administration after successful long-term therapy","volume":"28","author":"Price","year":"2007","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaci.2007.09.022_bib4","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S1081-1206(10)60027-0","article-title":"Systemic reaction to omalizumab","volume":"97","author":"Chipps","year":"2006","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2007.09.022_bib5","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/S1081-1206(10)63560-0","article-title":"Characterization of an anaphylactoid reaction to omalizumab","volume":"96","author":"Dreyfus","year":"2006","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2007.09.022_bib6","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jaci.2005.12.1303","article-title":"Second symposium on the definition and management of anaphylaxis: summary report\u2014Second National Institute of Allergy and Infectious Disease\/Food Allergy and Anaphylaxis Network symposium","volume":"117","author":"Sampson","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2007.09.022_bib7","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S1081-1206(10)60995-7","article-title":"Late-onset anaphylaxis to fermented soybeans: the first confirmation of food-induced, late-onset anaphylaxis by provocation test","volume":"94","author":"Inomata","year":"2005","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2007.09.022_bib8","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.jpeds.2006.06.048","article-title":"Delayed anaphylaxis to walnut following epinephrine administration","volume":"149","author":"Green","year":"2006","journal-title":"J Pediatr"},{"key":"10.1016\/j.jaci.2007.09.022_bib9","first-page":"421","article-title":"Late anaphylactic reaction to cuttlefish","volume":"63","author":"Shibasaki","year":"1989","journal-title":"Ann Allergy"},{"issue":"suppl 1","key":"10.1016\/j.jaci.2007.09.022_bib10","doi-asserted-by":"crossref","first-page":"S309","DOI":"10.1016\/j.jaci.2005.12.1221","article-title":"Delayed and recurrent anaphylaxis reaction to yellow jacket sting","volume":"117","author":"Ghaffari","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2007.09.022_bib11","doi-asserted-by":"crossref","first-page":"64","DOI":"10.2500\/aap.2007.28.2951","article-title":"Delayed food-dependent, exercise-induced anaphylaxis","volume":"28","author":"Oyefara","year":"2007","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaci.2007.09.022_bib12","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2500\/108854193778774001","article-title":"Systemic reactions to immunotherapy","volume":"14","author":"Matloff","year":"1993","journal-title":"Allergy Proc"},{"key":"10.1016\/j.jaci.2007.09.022_bib13","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0091-6749(88)91013-5","article-title":"Late systemic-allergic reactions to inhalant allergen immunotherapy","volume":"82","author":"Greenberg","year":"1988","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2007.09.022_bib14","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1111\/j.1398-9995.2007.01463.x","article-title":"Clinical presentation and time course in hypersensitivity reactions to beta-lactams","volume":"62","author":"Bousquet","year":"2007","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2007.09.022_bib15","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/mpo.2950080204","article-title":"Delayed allergic reactions following intramuscular L-asparaginase","volume":"8","author":"Spiegel","year":"1980","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.jaci.2007.09.022_bib16","first-page":"250","article-title":"Monoclonal antibodies, immunogenicity, and associated infusion reactions","volume":"72","author":"Cheifetz","year":"2005","journal-title":"Mt Sinai J Med"},{"key":"10.1016\/j.jaci.2007.09.022_bib17","unstructured":"Genentech Inc. Herceptin (trastuzumab): full prescribing information. 2000. Available at: http:\/\/www.gene.com.\/gene\/products\/information\/pdf\/herceptin-prescribing.pdf. Accessed September 24, 2007."},{"key":"10.1016\/j.jaci.2007.09.022_bib18","unstructured":"Roche Pharmaceuticals. Zenapax (daclizumab): full prescribing information. 2005. Available at: http:\/\/www.rocheusa.com\/products\/zenapax\/pi.pdf. Accessed September 24, 2007."},{"key":"10.1016\/j.jaci.2007.09.022_bib19","unstructured":"Novartis Pharmaceutical Corp. Simulect (basiliximab): full prescribing information. 2005. Available at: http:\/\/www.pharma.us.novartis.com\/product\/pi\/pdf\/simulect.pdf. Accessed September 24, 2007."},{"key":"10.1016\/j.jaci.2007.09.022_bib20","unstructured":"Wyeth Pharmaceuticals Inc. Mylotarg (gemtuzumab ozogamicin for injection): full prescribing information. 2007. Available at: http:\/\/www.wyeth.com\/content\/ShowLabeling.asp?id=119. Accessed on September 24, 2007."},{"key":"10.1016\/j.jaci.2007.09.022_bib21","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1553-2712.1997.tb03739.x","article-title":"Multiphasic anaphylaxis: an uncommon event in the emergency department","volume":"4","author":"Brady","year":"1997","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.jaci.2007.09.022_bib22","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1067\/mai.2001.119028","article-title":"Emergency department anaphylaxis: a review of 142 patients in a single year","volume":"108","author":"Brown","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2007.09.022_bib23","unstructured":"Briefing document on safety, BLA STN 103976\/0. US Food and Drug Administration. April 18, 2003. Available at: http:\/\/www.fda.gov\/ohrms\/dockets\/ac\/03\/briefing\/3952B1_02_FDA-Xolair-Safety.pdf. Accessed August 30, 2007."}],"updated-by":[{"DOI":"10.1016\/j.jaci.2007.12.002","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000}}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674907017812?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674907017812?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T01:06:40Z","timestamp":1677114400000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674907017812"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["S0091674907017812"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2007.09.022","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2007,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Delayed onset and protracted progression of anaphylaxis after omalizumab administration in patients with asthma","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2007.09.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}